You are here: Home » 2024 » September » Archives for 5th

Nyxoah Participera à de Prochaines Conférences d'Investisseurs

Nyxoah Participera à de Prochaines Conférences d'Investisseurs

Mont–Saint–Guibert, Belgique – 5 septembre 2024, 22:30 CET / 16:30 ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (« Nyxoah » ou la « Société ») opère dans le secteur des technologies médicales et se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La Société a annoncé aujourd'hui qu’elle participera à trois conférences d'investisseurs à New York.

Olivier Taelman, CEO de Nyxoah, présentera des mises à jour sur l'entreprise lors de la Baird Global Healthcare Conference, le mardi 10 septembre 2024, à 12h15 ET, lors de la H.C. Wainwright 26th Annual Global Investment Conference le mercredi 11 septembre 2024, à 11h00 ET et lors de la Cantor Global Healthcare Conference le mercredi 18 septembre 18 2024 à 13h55 ET. Les webcasts des présentations seront disponibles dans la section Events du site web des relations avec les investisseurs de Nyxoah. La société sera également disponible pour des réunions 1×1 avec les investisseurs institutionnels participant aux événements.

La présentation de Nyxoah aux investisseurs peut être consultée dans la section Shareholder Information de la page Investor Relations de la société.

À propos de Nyxoah

Nyxoah opère dans le secteur des technologies médicales. Elle se concentre sur le développement et la commercialisation de solutions innovantes destinées à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS). La principale solution de Nyxoah est le système Genio®, une thérapie de neurostimulation du nerf hypoglosse sans sonde et sans batterie qui a reçu le marquage CE, centrée sur le patient et destinée à traiter le Syndrome d’Apnées Obstructives du Sommeil (SAOS), le trouble respiratoire du sommeil le plus courant au monde. Ce dernier est associé à un risque accru de mortalité et des comorbidités, dont les maladies cardiovasculaires. La vision de Nyxoah est que les patients souffrant de SAOS doivent pouvoir profiter de nuits réparatrices et vivre pleinement leur vie.

Pour plus d’informations, visitez http://www.nyxoah.com/

Attention – Marquage CE depuis 2019. Dispositif expérimental aux États–Unis. Limité par la loi fédérale américaine à une utilisation expérimentale aux États–Unis.

Déclarations Prospectives

Certaines déclarations, croyances et opinions contenues dans le présent communiqué de presse sont de nature prospective et reflètent les attentes actuelles de la société ou, le cas échéant, des administrateurs ou de la direction de la société concernant le système Genio®, les études cliniques prévues et en cours sur le système Genio®, les avantages potentiels du système Genio® ; les objectifs de Nyxoah en ce qui concerne le développement, la voie réglementaire et l'utilisation potentielle du système Genio® ; l'utilité des données cliniques pour l'obtention éventuelle de l'approbation du système Genio® par la FDA ; et les résultats d'exploitation, la situation financière, les liquidités, les performances, les perspectives, la croissance et les stratégies de la société. De par leur nature, les déclarations prévisionnelles impliquent un certain nombre de risques, d'incertitudes, d'hypothèses et d'autres facteurs qui pourraient faire en sorte que les résultats ou événements réels diffèrent matériellement de ceux exprimés ou sous–entendus dans les déclarations prévisionnelles. Ces risques, incertitudes, hypothèses et facteurs pourraient avoir une incidence négative sur les résultats et les effets financiers des plans et des événements décrits dans le présent document. En outre, ces risques et incertitudes comprennent, sans s'y limiter, les risques et incertitudes énoncés dans la section ” Facteurs de risque ” du rapport annuel de la société sur le formulaire 20–F pour l'exercice clos le 31 décembre 2023, déposé auprès de la Securities and Exchange Commission (” SEC “) le 20 mars 2024, et des rapports ultérieurs que la Société dépose auprès de la SEC. Une multitude de facteurs, y compris, mais sans s'y limiter, les changements dans la demande, la concurrence et la technologie, peuvent faire en sorte que les événements, les performances ou les résultats réels diffèrent de manière significative de tout développement anticipé. Les déclarations prospectives contenues dans le présent communiqué de presse concernant des tendances ou des activités passées ne constituent pas des garanties de performances futures et ne doivent pas être considérées comme une déclaration selon laquelle ces tendances ou activités se poursuivront à l'avenir. En outre, même si les résultats ou développements réels sont conformes aux déclarations prospectives contenues dans le présent communiqué de presse, ces résultats ou développements peuvent ne pas être représentatifs des résultats ou développements des périodes futures. Aucune déclaration ou garantie n'est donnée quant à l'exactitude ou à la sincérité de ces déclarations prospectives. En conséquence, la société décline expressément toute obligation ou tout engagement de publier des mises à jour ou des révisions des déclarations prospectives contenues dans le présent communiqué de presse à la suite d'un changement des attentes ou d'un changement des événements, conditions, hypothèses ou circonstances sur lesquels ces déclarations prospectives sont basées, sauf si la loi ou la réglementation l'exige expressément. Ni la Société, ni ses conseillers ou représentants, ni aucune de ses filiales, ni les dirigeants ou employés de ces personnes ne garantissent que les hypothèses sous–jacentes à ces énoncés prospectifs sont exemptes d'erreurs et n'acceptent aucune responsabilité quant à l'exactitude future des énoncés prospectifs contenus dans le présent communiqué de presse ou à la survenance réelle des développements prévus. Vous ne devriez pas accorder une confiance excessive aux déclarations prospectives, qui ne sont valables qu'à la date du présent communiqué de presse.

Contacts :

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

Media
Belgique / France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

International/ Allemagne
MC Services – Anne Hennecke
anne.hennecke@mc–services.eu

Pièce jointe


GLOBENEWSWIRE (Distribution ID 1000990281)

Nyxoah to Participate in Upcoming Investor Conferences

Nyxoah to Participate in Upcoming Investor Conferences

Mont–Saint–Guibert, Belgium – September 5, 2024, 10:30pm CET / 4:30pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today announced that the Company will participate in three upcoming investor conferences in New York City.

Olivier Taelman, Nyxoah’s Chief Executive Officer, will deliver corporate updates at the Baird Global Healthcare Conference on Tuesday, September 10, 2024, at 12:15pm ET, the H.C. Wainwright 26th Annual Global Investment Conference on Wednesday, September 11, 2024, at 11:00am ET and the Cantor Global Healthcare Conference on Wednesday, September 18, 2024 at 1:55pm ET. Webcasts of the presentations will be available on the Events section of Nyxoah’s Investor Relations website. The Company will also be available for 1×1 meetings with institutional investors attending the events.

Nyxoah’s Investor Presentation can be accessed on the Shareholder Information section of the Company’s Investor Relations page.

About Nyxoah

Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient–centered, leadless and battery–free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest. 

For more information, please see the Company’s annual report for the financial year 2023 and visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward–looking statements

Certain statements, beliefs and opinions in this press release are forward–looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the entry into of the loan facility agreement and the synthetic warrant agreement with the EIB; the use of proceeds from the loan facility agreement; the Genio® system and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; reporting data from Nyxoah’s DREAM U.S. pivotal trial; filing for FDA approval; and entrance to the U.S. market. By their nature, forward–looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward–looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20–F for the year ended December 31, 2023, filed with the Securities and Exchange Commission (“SEC”) on March 20, 2024, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward–looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward–looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward–looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward–looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person's officers or employees guarantees that the assumptions underlying such forward–looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward–looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward–looking statements, which speak only as of the date of this press release.

Contacts:

Nyxoah
Loïc Moreau, Chief Financial Officer
IR@nyxoah.com

For Media
Belgium/France
Backstage Communication – Gunther De Backer
gunther@backstagecom.be

International/Germany
MC Services – Anne Hennecke
nyxoah@mc–services.eu

Attachment


GLOBENEWSWIRE (Distribution ID 1000990281)

Nikkiso Clean Energy & Industrial Gases Group and GTT Announce Partnership to Advance LNG-Fueled Shipping Market

TEMECULA, Calif., Sept. 05, 2024 (GLOBE NEWSWIRE) — Nikkiso Clean Energy & Industrial Gases Group, part of Nikkiso Co. Ltd.’s Industrial Business segment, and GTT announced today they have entered into a partnership to support the LNG–fueled cargo shipping market. The partnership between Nikkiso CE&IG and GTT brings together cutting–edge engineering and technology for LNG membrane containment and process systems and best–in–class hardware, global manufacturing and technical integration competencies.

GTT’s patented Recycool™ technology ensures boil–off gas (BOG) is recovered and managed safely to avoid unwanted emissions and improve fuel efficiency. Integrated with Nikkiso’s high–pressure fuel gas pump skids, the partnership provides ship owners with enhanced performance by maintaining reliability durability and efficiency to give customers a competitive edge in the market.

“Our partnership with GTT and complementary expertise advances the growth of both companies in the LNG–fuelled shipping market,” said Nikkiso Clean Energy & Industrial Gases CEO Adrian Ridge. “This strength is evidenced by the first large order for 10 container ships, and we expect more awards in the future.”

Jean–Baptiste Choimet, Chief Executive Officer of GTT, stated: “I’d like to thank the Nikkiso team for their support and collaboration. With GTT’s expertise in reducing boil–off rates through our membrane technology, the Recycool™ system now provides LNG–fueled vessels with effective solutions for managing boil–off and lowering their carbon footprint. The adoption of Recycool™ by leading Chinese and Korean shipyards reflects the industry's trust in this solution.”

The value of this partnership has already been recognized by large ship owners with a recent award from a leading shipping operator and numerous projects under negotiation for a variety of ship types.

About Nikkiso Clean Energy & Industrial Gases Group

The Nikkiso Clean Energy & Industrial Gases Group is a leading provider of cryogenic equipment, technologies and applications for clean energy and industrial gas market segments. The Group employs more than 1,700 people in 22 countries and is headed by Cryogenic Industries, Inc. in Southern California, U.S., which is a wholly owned subsidiary of Nikkiso Co., Ltd. (TSE: 6376).

Media contact
pr@nikkisoceig.com

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/8254d660–5938–486d–af42–c71dbf70962f


GLOBENEWSWIRE (Distribution ID 9226105)

Foreign Investors in SouthFace Village at Okemo (JF36) Project Obtain Conditional Green Card Approvals

WASHINGTON, Sept. 05, 2024 (GLOBE NEWSWIRE) — EB5 Capital is pleased to announce the first two I–526E petition approvals for investors in its SouthFace Village at Okemo (JF36) project. An I–526E approval is a significant step in the EB–5 immigration process as it qualifies the investor and their eligible immediate family members for conditional permanent residency in the United States. The approved petitions were filed in December 2023 and January 2024.

The SouthFace Village at Okemo (JF36) project is a $103.8 million residential development containing 26 mountain chalets, 24 fully–furnished townhomes, and 6 condominiums, spanning 200–acres on the south face of Okemo Mountain, located in Ludlow, Vermont. EB5 Capital raised foreign capital from 37 investors, representing a variety of nationalities, to finance a portion of the capital stack.

“We are pleased to have received the first I–526E approvals for this project,” said Molly FitzGerald, Director of Investor Communications and Engagement at EB5 Capital. “This significant milestone underscores our commitment to providing exceptional EB–5 qualifying investment opportunities to investors.”

To date, EB5 Capital has raised foreign investor funds across over 40 EB–5 projects throughout the United States. JF36 is EB5 Capital’s 31st project which has reached the conditional green card stage for foreign investors going through the EB–5 immigration process. Now that the first petitions have been approved, additional I–526E petition adjudications for this project are expected in the coming months.

About EB5 Capital

EB5 Capital provides qualified foreign investors with opportunities to invest in job–creating commercial real estate projects under the United States Immigrant Investor Program (EB–5 Visa Program). Headquartered in Washington, DC, EB5 Capital’s distinguished track record and leadership in the industry has attracted investors from over 75 countries. As one of the oldest and most active Regional Center operators in the country, the firm has raised over $1 billion of foreign capital across approximately 40 EB–5 projects. 100% of our investors’ funds are protected by the Federal Deposit Insurance Corporation (FDIC) insurance prior to their deployment into our projects. Please visit www.eb5capital.com for more information.  

Contact:
Katherine Willis
Director, Marketing & Communications
media@eb5capital.com 


GLOBENEWSWIRE (Distribution ID 9226075)

AI-Media to Showcase Cutting-Edge Alta Platform Innovations at IBC 2024

LONDON, Sept. 05, 2024 (GLOBE NEWSWIRE) — AI–Media, the leader in live video captioning and subtitling solutions, is set to unveil a suite of groundbreaking updates to its Alta platform at the International Broadcasting Convention (IBC) 2024 happening in Amsterdam, 13–16 September. As broadcasters across the globe seek to modernize workflows and improve accessibility, AI–Media continues to deliver innovative solutions that address the industry's most pressing challenges.

Strategic Focus at IBC 2024

At IBC 2024, AI–Media will focus on expanding its footprint in the European market with its LEXI broadcast workflow, emphasizing solutions that deliver cost savings and workflow efficiencies. The primary highlights will include:

  • LEXI Live AI–Powered Captions: Offering hands–on trials to demonstrate the power, low–latency and accuracy of AI–Media's automated captioning.
  • Gold standard SDI and video IP caption encoder tech trusted by major global broadcasters.
  • File–based Solutions: Promoting new solutions for video–on–demand captioning workflows.
  • Multilingual Captions and Translation: Showcasing solutions that support multiple languages to cater to diverse audiences.
  • Innovation Station: showcasing new tech on the horizon including LEXI Live Voice dubbing, LEXI automated audio description, generative AI topic modelling, automated sound effects recognition plus more.

AI–Media's Value Proposition

For EMEA broadcasters, AI–Media offers turnkey subtitling solutions that integrate seamlessly into existing workflows, backed by over 20 years of in–field experience and a proven track record of delivering cost savings and workflow efficiencies for their customers. As a trusted partner to major broadcasters globally, AI–Media is committed to ongoing investment and innovation in subtitling solutions.

Revolutionary Alta Platform Enhancements

AI–Media's latest updates to the Alta platform underscore the company’s commitment to delivering cutting–edge technology for live video captioning and subtitling:

  • SMPTE ST 2110–43 Support: AI–Media's Alta now supports outputting live captions in a 2110–43 stream, leveraging the popular standard for transporting Timed Text Markup Language (TTML) within 2110 streams. This enables broadcasters to send non–Latin character sets in low bandwidth and facilitates easy integration with third–party systems, as well as conversion to online formats for OTT distribution.
  • Audio Dubbing Capabilities: LEXI audio dubbing support in Alta TS. Broadcasters will be able to create synthetically dubbed audio tracks in multiple languages, which can be inserted into MPEG TS output streams, offering new layers of accessibility.
  • SCTE Trigger Automation: Alta's LEXI triggering automation enables automated control of captions during ad breaks. LEXI captions will automatically pause, or resume based on SCTE triggers, streamlining ad break management. Triggers can also be used to position captions.
  • DVB Subs Customization: Alta TS now allows end users to configure DVB Subs/bitmap caption appearance, including font size, colours, and positioning. This supports image–based characters, expanding accessibility for Asian languages.
  • Google Cloud Deployment: In addition to AWS, Alta is now deployable in Google Cloud, providing broadcasters with more cloud–based alternatives to enhance their operations.

The latest updates to the Alta platform are game–changers for broadcasters, offering unparalleled automation, flexibility, efficiency, and accessibility enhancements that meet the demands of modern media environments, from cloud–native deployments to advanced automation and multilingual support.

Visit AI–Media at IBC 2024

Experience AI–Media's latest innovations at IBC 2024 and discover why broadcasters worldwide trust AI–Media to transform their captioning workflows. To book a 1:1 meeting click HERE. For more information, visit ai–media.tv.

Watch an interview between James Ward, Chief Sales Officer at AI–Media and TVB Europe about AI–Media's planned showcase for IBC Show 2024.

About AI–Media

Founded in Australia in 2003, AI–Media is a pioneering technology company specialising in AI language and captioning workflow solutions.

As a global leader, AI–Media provides high–quality AI–powered live and recorded captioning and translation technology and solutions to a diverse range of customers and markets worldwide.

For the first time in February 2024, AI–Media unveiled groundbreaking data showcasing the superiority of its AI captioning product, LEXI, over traditional more expensive human workflows.

With deep industry experience and sophisticated AI technology to create solutions which streamline and simplify processes, AI–Media empowers leading broadcasters, enterprises and government agencies globally to ensure seamless accessibility and inclusivity of their content.

AI–Media (ASX: AIM) commenced trading on the ASX on 15 September 2020.   

Media Contact: Fiona Habben – Fiona.habben@ai–media.tv

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/00176e34–613c–44dd–9daa–e1ec76c395d3


GLOBENEWSWIRE (Distribution ID 9225725)

Climate Action Greatest Economic Opportunity of this Century, Says UN Climate Chief

With fewer than 100 days to go to COP29, the highest decision-making body on climate issues under the United Nations Framework Convention on Climate Change (UNFCCC), the need for creative and innovative solutions to protect lives and livelihoods is now extremely urgent. The State of the Climate in Africa 2023 report shows all six African […]

INDIA: ‘Civil Society Organisations Are at the Forefront of the Fight Against Gender-based Violence’

By CIVICUS
Sep 5 2024 –  
CIVICUS discusses the recent wave of protests against gender-based violence (GBV) in India with Dr Kavitha Ravi, a member of the Indian Medical Association (IMA).

Protests erupted across India after a 31-year-old female medical trainee was raped and murdered in a Kolkata hospital on 9 August. The IMA called a strike, with protests held in major cities including Kolkata and Mumbai. While the official strike has ended, many doctors, particularly junior doctors, remain on strike and protests continue to demand justice, accountability and safer working conditions for women.

Kavitha Ravi

What triggered the recent protests against GBV in India?

Protests erupted after the tragic rape and murder of a young female doctor at the R G Kar Medical College in Kolkata on 9 August. This horrific incident shocked the nation and sparked widespread outrage. In response, a coalition of doctors, medical associations such as the IMA and various resident and faculty associations joined together in a nationwide strike to demand justice for the victim and better safety measures for health workers, particularly women who face significant risks in the workplace.

Protesters are calling for major reforms, including the adoption of a Hospital Protection Act, which would designate hospitals as safe zones and introduce measures to create a safer environment for health workers. Their demands are part of a larger movement to comprehensively address GBV, prevent similar tragedies in the future and create a safer and more supportive working environment for everyone in the health sector.

What steps have been taken so far to ensure justice and the safety of female health workers?

The judicial system has acted swiftly by transferring the case to a higher authority to ensure a thorough investigation after concerns were raised about the police’s initial inquiry, which was not accepted by the students or the victim’s family. They were sceptical, believing the police might be favouring the college authorities and supporting the accused.

This decision aims to ensure a detailed investigation so justice can be done. The Supreme Court of India is also overseeing the case to monitor its progress, address any issues that may arise and ensure all necessary steps are taken to uphold justice.

In parallel, several initiatives are underway to improve the safety of female health workers. The Ministry of Health has proposed establishing a committee to review and improve safety protocols in health facilities. There are also plans to increase security in hospitals and establish a new national taskforce dedicated to improving safety through better infrastructure, advanced technology and additional security measures. However, despite these efforts, more needs to be done to combat GBV and ensure that these measures effectively protect female health workers.

How have the authorities responded to the protests?

The authorities have taken a mixed approach to the nationwide strike, combining concessions with new measures to address immediate concerns. The Health Ministry has drawn up a detailed plan to increase security in central government hospitals. This includes installing high-resolution CCTV cameras, monitoring access points with identification badges, deploying trained security personnel for constant patrolling and securing duty rooms for female staff. Hospitals are also encouraged to develop and regularly update emergency response plans and conduct mock drills.

In response to these measures, the IMA suspended its strike. However, other doctors’ associations have continued to protest for more substantial reforms. Many people remain dissatisfied, particularly after recent incidents of police violence. While the Supreme Court’s intervention may have temporarily eased the tensions, protesters remain concerned about the new measures’ effectiveness and full implementation.

Why is GBV so prevalent in India, and what’s being done about it?

Deep-rooted cultural, social, economic and legal factors account for the high prevalence of GBV in India. This is a patriarchal country where traditional gender roles and the subjugation of women are deeply entrenched. Women tend to be economically dependent on men, which traps them in abusive relationships that make it difficult for them to seek help or escape. Intergenerational cycles of violence perpetuate the problem, as children who witness or experience abuse may come to see such behaviour as normal.

Low literacy rates, particularly in rural areas, further limit women’s understanding of their rights and the available support. When they do seek justice, the system often fails to protect the victims or hold perpetrators accountable. Systemic failures in law enforcement and justice help perpetuate GBV.

Many initiatives and campaigns have helped highlight and address this issue. But it has not been easy. A lack of consistent political will and weak implementation of policies have hindered substantial change. Feminist and social justice movements often face resistance from conservative parts of society, making it difficult to change these deeply entrenched cultural norms.

To combat GBV effectively, we need a comprehensive approach that includes better education, legal reform, economic empowerment and cultural change. Civil society organisations are at the forefront of this fight, actively advocating for stronger laws, better enforcement and increased public awareness. Continued and robust efforts are essential to address this widespread problem and ensure meaningful change.

Civic space in India is rated ‘repressed’ by the CIVICUS Monitor.

Get in touch with the Indian Medical Association through its website or Facebook page, and follow @IMAIndiaOrg on Twitter.

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

The Time to End Nuclear Tests is Now

A nuclear test is carried out on an island in French Polynesia in 1971. In 2009 the United Nations General Assembly proclaimed 29 August the International Day Against Nuclear Tests. Credit: CTBTO

By Dennis Francis
UNITED NATIONS, Sep 5 2024 – Today, the General Assembly convenes – for the fifteenth consecutive occasion – to observe the International Day Against Nuclear Tests, which is commemorated annually on 29 August.

On this day, 33 years ago, the Semipalatinsk Nuclear Test Site in Kazakhstan – where the former Soviet Union conducted 456 nuclear tests – was permanently closed, marking a pivotal moment in the global effort to end unrestrained nuclear testing.

We observe this Day in honor and in remembrance of the victims, and in support of all the survivors – mindful of our collective responsibility to ensure that our moral compass stays attuned to the enduring impact of nuclear testing on people’s lives, livelihoods, health, and the environment.

Importantly, it is a day to reaffirm our commitment to ending nuclear testing – once and for all.

Despite the progress made to date – and the universal understanding of the existential dangers posed by nuclear weapons – the threat they pose still looms unacceptably large, exacerbated by a world once again torn apart by conflict and strife.

Geopolitical tensions are at their highest in decades – from Europe to the Middle East, from Africa to Asia. As a result, the global nuclear disarmament and non-proliferation regime faces significant setbacks.

In recent years, we have witnessed the return of dangerous, irresponsible, and reckless rhetoric – suggesting that the real risk of resort to nuclear arms may, once again, not be a far-fetched reality; be it intentionally or by accident.

We have also heard talk of maintaining the readiness of nuclear testing sites – with the possibility of resuming nuclear tests if deemed necessary.

We have even seen a nuclear-armed State revoke its ratification of the Comprehensive Nuclear-Test-Ban Treaty. I am deeply concerned by these developments – as it seems that we have not yet learned from the painful lessons of the past.

I am deeply troubled by the message these actions send to all other nations – perhaps even emboldening some to reconsider their arms control commitments, thus further endangering global peace and security.

It is our collective responsibility to ensure that we do not turn back the clock and allow the same mistakes to occur once more – with even graver consequences. With even graver consequences.

The Comprehensive Nuclear-Test-Ban Treaty (CTBT) remains our best safety net to ensure that nuclear testing stays where it belongs – in the past. Since its adoption in 1996, the CTBT has garnered near-universal international support.

It is encouraging that, to date, 187 Member States have signed the treaty, and 178 have ratified it. I commend Papua New Guinea as the most recent Member State to ratify the treaty in 2023. The treaty’s benefits to international peace and security are evident in the numbers.

Before 1996, over two thousand nuclear weapons tests were conducted; and since then, there have been fewer than a dozen.

However – in the face of heightened geopolitical tensions – we cannot take anything for granted.

I take this opportunity to urge all Member States that have not yet signed or ratified the treaty to do so without delay – particularly the Annex 2 States, whose ratifications are essential for the treaty’s entry into force.

As I conclude, it is worth emphasizing that history reminds us of the horrors of war and the tragic misuse of human ingenuity to create even more lethal weapons.

And nuclear arms stand as the ultimate manifestation of this dark legacy.

Complacency in the face of these threats risk nothing less than the end of civilization as we know it. Now – more than ever – we must reaffirm our commitment to upholding and enforcing the norm against nuclear testing.

Any threats, preparations, or declarations of readiness to resume testing demand our united and unequivocal condemnation. And should any such tests occur, they must be met with swift and decisive collective action.

The time to end nuclear tests – once and for all – is now, not tomorrow, but NOW.

This article is based on remarks by the President of the General Assembly, Dennis Francis, at the High-level plenary meeting of the General Assembly to commemorate and promote the International Day against Nuclear Tests.

IPS UN Bureau

 


!function(d,s,id){var js,fjs=d.getElementsByTagName(s)[0],p=/^http:/.test(d.location)?’http’:’https’;if(!d.getElementById(id)){js=d.createElement(s);js.id=id;js.src=p+’://platform.twitter.com/widgets.js’;fjs.parentNode.insertBefore(js,fjs);}}(document, ‘script’, ‘twitter-wjs’);  

JMGO setzt auf der IFA 2024 mit der MALC™ 2.0 Triple Laser Optics neue Maßstäbe im Bereich Laserprojektion

BERLIN, Sept. 05, 2024 (GLOBE NEWSWIRE) — JMGO, ein Vorreiter auf dem Gebiet der optischen Technologie, wird auf der IFA 2024 in Berlin seine eigens entwickelte MALC™ (Microstructure Adaptive Laser Control) 2.0 Triple Laser Optics vorstellen. Diese Innovation ermöglicht gleichzeitig eine hohe Helligkeit, maximalen Kontrast und lebendige Farben und wird die Industrie der Laserprojektion revolutionieren.

Die Lasertechnologie ist bekannt für ihre unübertroffene Helligkeit und Farbwiedergabe im Vergleich zu LED– und lampenbasierten Systemen. Allerdings war der Kompromiss zwischen Helligkeit, Kontrast und Farbe eine große Herausforderung für Laser– und Hybrid–Laser/LED–Projektoren. Eine Erhöhung der Helligkeit führt in der Regel zu einer Verringerung des Kontrasts und zu einer Übersättigung der Farben, während eine Erhöhung der Farbsättigung häufig zu einer Verringerung der Helligkeit und damit zu einer Beeinträchtigung des gesamten Seherlebnisses führt.

Mit der MALC™ 2.0 Triple Laser Optics durchbricht JMGO diese Barriere und ermöglicht mit den Projektoren der N1S–Serie eine Helligkeit von bis zu 3.500 ANSI–Lumen, ein beeindruckendes FOFO–Kontrastverhältnis von 1.600:1 und eine 110–prozentige Abdeckung des BT.2020–Farbraums mit einer Farbgenauigkeit von Δ<1. Das bedeutet, dass Zuschauer lebensechte Bilder mit brillanter Helligkeit, starkem Kontrast und präziser Farbwiedergabe genießen können – ohne Abstriche bei der Bildqualität machen zu müssen.

Durch den Einsatz von neun patentierten Technologien verbessert die MALC™ 2.0 auch die Helligkeitskonstanz, reduziert den Speckle–Effekt und erhöht die optische Effizienz – bei gleichzeitig deutlich reduzierten Produktionskosten. Diese technischen Neuerungen werden auf der Presseveranstaltung am 7. September um 14:00 Uhr im Detail vorgestellt.

„Die MALC™ 2.0 Triple Laser Optics ist Ausdruck unseres unermüdlichen Bestrebens, die anspruchsvollsten Herausforderungen der Branche zu meistern“, so Forrest Li, CEO von JMGO. „Als führendes Unternehmen auf dem Gebiet der Laserprojektion sind wir stets bestrebt, neue Standards in der Forschung und Entwicklung zu setzen und erstklassige Seherlebnisse mit kompromissloser Bildqualität zu bieten.“

Am Stand H20–104 auf der Messe Berlin wird JMGO auch seine neuen MALC™ 2.0–betriebenen Projektoren einschließlich des Spitzenmodells N1S Ultimate 4K vorstellen. Besucher haben die Möglichkeit, diese bahnbrechenden Innovationen aus erster Hand zu erleben und an interaktiven Aktivitäten wie der 120S Color Challenge und Space of Imagination teilzunehmen, die die einzigartigen Vorteile der MALC™ 2.0 demonstrieren.

Über JMGO
Seit 2011 hat sich JMGO dem Ziel verschrieben, immersive Großbildschirm–Erlebnisse mit Mobilität und Vielseitigkeit zu bieten. Mit funktionalem Design und hochwertiger Unterhaltung will JMGO ein in der Branche einzigartiges All–in–One Home–Entertainment–Ökosystem aufbauen, das Endgerät, Inhalte, Plattform und Software für einen globalen Markt umfasst.

Ein Foto zu dieser Meldung finden Sie unter https://www.globenewswire.com/NewsRoom/AttachmentNg/cdb29a3c–a102–4c96–8d94–ac18b29370a0


GLOBENEWSWIRE (Distribution ID 9225808)

JMGO s’apprête à révolutionner la projection laser à l’IFA 2024 grâce à son triple laser MALC™ 2.0

BERLIN, 05 sept. 2024 (GLOBE NEWSWIRE) — Pionnier de la technologie optique, JMGO présentera son triple laser MALC™ (Microstructure Adaptive Laser Control) 2.0 développé en interne, à l’IFA 2024, à Berlin. Cette innovation devrait redéfinir la projection laser en surmontant l’éternel défi de l’industrie : obtenir simultanément une luminosité, un contraste et des couleurs élevés.

La technologie laser est réputée offrir une luminosité et des couleurs incomparables par rapport aux systèmes à LED et à lampes. Cependant, le compromis entre luminosité, contraste et couleur constitue un obstacle important pour les projecteurs laser et hybrides laser/LED. Généralement, l’augmentation de la luminosité réduit le contraste et sursature les couleurs, tandis que la priorité accordée à la couleur entraîne souvent une luminosité plus faible, altérant l’expérience visuelle globale.

Le triple laser MALC™ 2.0 de JMGO élimine ces obstacles en permettant aux projecteurs de la série N1S de fournir jusqu’à 3 500 lumens ANSI de luminosité tout en conservant simultanément un impressionnant rapport de contraste FOFO de 1 600:1 et en couvrant 110 % de BT.2020 avec une précision des couleurs de Δ<1. Les spectateurs peuvent ainsi profiter d’images réalistes avec une luminosité exceptionnelle, un contraste profond et une reproduction précise des couleurs, sans aucun compromis sur la qualité d’image.

Doté de neuf technologies brevetées, le moteur laser MALC™ 2.0 améliore également l’uniformité de la luminosité, réduit les taches laser et améliore l’efficacité optique, tout en réduisant considérablement les coûts de production. Ces innovations seront détaillées lors de la conférence de presse du 7 septembre à 14 h.

« Le triple laser MALC™ 2.0 incarne notre volonté farouche de surmonter les défis les plus difficiles de l’industrie », a déclaré Forrest Li, PDG de JMGO. « En tant qu’experts de la projection laser, nous sommes toujours à l’avant–garde des avancées en matière de R&D et établissons de nouvelles normes en offrant des expériences visuelles haut de gamme avec une qualité d’image sans compromis. »

Au stand H20–104 du Messe Berlin, JMGO présentera également ses nouveaux projecteurs alimentés par le MALC™ 2.0, tels que son produit phare, le N1S Ultimate 4K. Les visiteurs pourront découvrir ces innovations et participer à des activités interactives telles que le 120S Color Challenge et Space of Imagination, pensés pour mettre en avant les atouts uniques du MALC™ 2.0.

À propos de JMGO
Depuis 2011, JMGO s’attache à proposer des expériences immersives sur grand écran alliant portabilité et polyvalence. En misant sur une conception fonctionnelle et un divertissement de haute qualité, JMGO ambitionne de créer un écosystème de divertissement à domicile tout–en–un, le premier du secteur qui englobe le terminal, le contenu, la plate–forme et les logiciels à destination d’un marché mondial.

Une photo accompagnant cette annonce est disponible à l’adresse suivante : https://www.globenewswire.com/NewsRoom/AttachmentNg/cdb29a3c–a102–4c96–8d94–ac18b29370a0


GLOBENEWSWIRE (Distribution ID 9225808)